These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3906073)

  • 21. Indomethacin for the prevention of symptomatic patent ductus arteriosus in very low birth weight infants.
    Lai TH; Soong WJ; Hwang B
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1990; 31(1):17-23. PubMed ID: 2278224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Shah SS; Ohlsson A
    Cochrane Database Syst Rev; 2003; (2):CD004213. PubMed ID: 12804505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity.
    Hammerman C; Glaser J; Kaplan M; Schimmel MS; Ferber B; Eidelman AI
    Pediatrics; 1998 Nov; 102(5):E56. PubMed ID: 9794986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
    Herrera C; Holberton J; Davis P
    Cochrane Database Syst Rev; 2004; (1):CD003480. PubMed ID: 14974018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of the efficacy of ibuprofen and indomethacin in the treatment of patent ductus arteriosus in prematurely born infants].
    Adamska E; Helwich E; Rutkowska M; Zacharska E; Piotrowska A
    Med Wieku Rozwoj; 2005; 9(3 Pt 1):335-54. PubMed ID: 16547381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged bleeding time in preterm infants receiving indomethacin for patent ductus arteriosus.
    Corazza MS; Davis RF; Merritt TA; Bejar R; Cvetnic W
    J Pediatr; 1984 Aug; 105(2):292-6. PubMed ID: 6747765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study.
    Yanagi RM; Wilson A; Newfeld EA; Aziz KU; Hunt CE
    Pediatrics; 1981 May; 67(5):647-52. PubMed ID: 7019841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurodevelopmental outcome at 36 months' corrected age of preterm infants in the Multicenter Indomethacin Intraventricular Hemorrhage Prevention Trial.
    Ment LR; Vohr B; Oh W; Scott DT; Allan WC; Westerveld M; Duncan CC; Ehrenkranz RA; Katz KH; Schneider KC; Makuch RW
    Pediatrics; 1996 Oct; 98(4 Pt 1):714-8. PubMed ID: 8885951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of symptomatic patent ductus arteriosus with a single dose of indomethacin.
    Krueger E; Mellander M; Bratton D; Cotton R
    J Pediatr; 1987 Nov; 111(5):749-54. PubMed ID: 3312552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study.
    Gersony WM; Peckham GJ; Ellison RC; Miettinen OS; Nadas AS
    J Pediatr; 1983 Jun; 102(6):895-906. PubMed ID: 6343572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antenatal steroids, delivery mode, and intraventricular hemorrhage in preterm infants.
    Ment LR; Oh W; Ehrenkranz RA; Philip AG; Duncan CC; Makuch RW
    Am J Obstet Gynecol; 1995 Mar; 172(3):795-800. PubMed ID: 7892866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants.
    Cordero L; Nankervis CA; Gardner D; Giannone PJ
    J Perinatol; 2007 Jan; 27(1):22-7. PubMed ID: 17053778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indomethacin prophylaxis to prevent intraventricular hemorrhage: association between incidence and timing of drug administration.
    Mirza H; Oh W; Laptook A; Vohr B; Tucker R; Stonestreet BS
    J Pediatr; 2013 Sep; 163(3):706-10.e1. PubMed ID: 23522865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of indomethacin prophylaxis timing on intraventricular haemorrhage and patent ductus arteriosus in extremely low birth weight infants.
    Mirza H; Laptook AR; Oh W; Vohr BR; Stoll BJ; Kandefer S; Stonestreet BS;
    Arch Dis Child Fetal Neonatal Ed; 2016 Sep; 101(5):F418-22. PubMed ID: 26733540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ibuprofen--a new application for pharmacological closure of patent ductus arteriosus in preterm infants. Preliminary report].
    Adamska E
    Med Wieku Rozwoj; 2000; 4(2 Suppl 3):65-71. PubMed ID: 11328971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
    Malviya M; Ohlsson A; Shah S
    Cochrane Database Syst Rev; 2003; (3):CD003951. PubMed ID: 12917997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treating extremely low birthweight infants with prophylactic indomethacin. Evidence for short term benefits only.
    McGuire W; Fowlie PW
    BMJ; 2002 Jan; 324(7329):60-1. PubMed ID: 11786435
    [No Abstract]   [Full Text] [Related]  

  • 38. Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial.
    Van Overmeire B; Allegaert K; Casaer A; Debauche C; Decaluwé W; Jespers A; Weyler J; Harrewijn I; Langhendries JP
    Lancet; 2004 Nov 27-Dec 3; 364(9449):1945-9. PubMed ID: 15567010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic indomethacin: systematic review and meta-analysis.
    Fowlie PW
    Arch Dis Child Fetal Neonatal Ed; 1996 Mar; 74(2):F81-7. PubMed ID: 8777672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Administration of indomethacin for the prevention of periventricular-intraventricular hemorrhage in high-risk neonates.
    Hanigan WC; Kennedy G; Roemisch F; Anderson R; Cusack T; Powers W
    J Pediatr; 1988 Jun; 112(6):941-7. PubMed ID: 3373404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.